In a new draft guidance, issued on October 29, 2025, the FDA proposed major updates to simplify biosimilarity studies and potentially reduce ...
Salesforce advances with Agentforce traction, FY30 targets, AI efficiencies, double-digit growth, margin gains and strong ...
Salesforce shows double-digit growth, strong AI momentum, high margins, peer discount, and long-term upside with a $292 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback